Novartis buys gene therapy developer Kate
| BPLSX Fund | USD 15.58 0.01 0.06% |
Slightly above 56% of Boston Partners' investor base is looking to short. The analysis of overall sentiment of trading Boston Partners Longshort mutual fund suggests that many investors are alarmed at this time. Boston Partners' investing sentiment can be driven by a variety of factors including economic data, Boston Partners' earnings reports, geopolitical events, and overall market trends.
Boston |
Novartis acquires gene therapy developer Kate Therapeutics for up to 1.1B, expanding expertise in neuromuscular diseases. Read more here.
Read at seekingalpha.com
 |
Boston Partners Fundamental Analysis
We analyze Boston Partners' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boston Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boston Partners based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Boston Partners is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Boston Partners Longshort Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Boston Partners mutual fund to make a market-neutral strategy. Peer analysis of Boston Partners could also be used in its relative valuation, which is a method of valuing Boston Partners by comparing valuation metrics with similar companies.
Peers
Boston Partners Related Equities
| MFLDX | Marketfield Fund | 0.46 | ||||
| DIAMX | Diamond Hill | 0.39 | ||||
| BPIRX | Boston Partners | 0.19 | ||||
| BPLEX | Boston Partners | 0.08 | ||||
| COAGX | Caldwell Orkin | 0.34 |
Other Information on Investing in Boston Mutual Fund
Boston Partners financial ratios help investors to determine whether Boston Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Partners security.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |